Isoniazid (H)

DRUG6 trials

Sponsors

University of Oxford, University College, London, Shenzhen Third People's Hospital, Shanghai Pulmonary Hospital, Shanghai, China

Conditions

Drug-Susceptible Pulmonary TuberculosisPulmonary TuberculosisTuberculosisTuberculosis (TB)Tuberculosis, Pulmonary

Phase 1

PK Study of Anti-TB Drugs

CompletedNCT02457208

University of OxfordTuberculosis

Start: 2015-07-07End: 2018-01-14Updated: 2018-10-03

Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

RecruitingNCT06114628

University College, LondonPulmonary Tuberculosis

Start: 2024-01-09End: 2027-08-11Target: 2500Updated: 2025-10-06

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not yet recruitingNCT07129629

Shanghai Pulmonary Hospital, Shanghai, ChinaDrug-Susceptible Pulmonary Tuberculosis, Tuberculosis, Pulmonary

Start: 2025-08-20End: 2027-12-31Target: 45Updated: 2025-08-19

Phase 3

A PAN-USR TB Multi-Center Trial

RecruitingNCT06905522

Shenzhen Third People's HospitalPulmonary Tuberculosis

Start: 2025-06-18End: 2029-12-31Target: 610Updated: 2025-12-01

Ultra-Short Regimen for Elderly DS-TB

Not yet recruitingNCT07076225

Shenzhen Third People's HospitalPulmonary Tuberculosis

Start: 2025-07-25End: 2030-07-31Target: 300Updated: 2025-07-22

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Not yet recruitingNCT07163143

University College, LondonTuberculosis (TB)

Start: 2025-11-30End: 2029-04-30Target: 784Updated: 2025-09-09